Parecoxib Sodium contains not less than 98.5% and not more than 101.5% of C19H17N2O4SNa, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

丙醯胺刻熄鈉鹽
Parecoxib Sodium

• 申請商: 恒亞貿易股份有限公司
• 適應症: 使用於外科手術後疼痛之緩解
• 發證日期: 2022-01-25